SPDR S&P Biotech ETF $XBI Shares Sold by Lyell Wealth Management LP

Lyell Wealth Management LP lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 77.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,288 shares of the exchange traded fund’s stock after selling 11,240 shares during the period. Lyell Wealth Management LP’s holdings in SPDR S&P Biotech ETF were worth $273,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. DHJJ Financial Advisors Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $25,000. Garrison Bradford & Associates Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $39,000. Compass Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 46.0% during the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after buying an additional 200 shares during the last quarter. Golden State Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 319 shares during the last quarter. Finally, Avalon Trust Co acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $57,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $110.17 on Tuesday. The company has a 50 day simple moving average of $96.56 and a 200-day simple moving average of $86.95. The company has a market capitalization of $6.84 billion, a P/E ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $110.96.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.